𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Frequent upregulation of MYC in plasma cell leukemia

✍ Scribed by Laura Chiecchio; Gian Paolo Dagrada; Helen E. White; Mark R. Towsend; Rebecca K. M. Protheroe; Kan Luk Cheung; David M. Stockley; Kim H. Orchard; Nicholas C. P. Cross; Christine J. Harrison; Fiona M. Ross


Book ID
102221724
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
342 KB
Volume
48
Category
Article
ISSN
1045-2257

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Plasma cell leukemia (PCL) is a rare form of monoclonal gammopathy, which can originate de novo or evolve from multiple myeloma (MM) as a terminal leukemic phase. Previous cytogenetic studies of PCL have reported the presence of complex karyotypes with involvement of multiple unidentified chromosomal regions. We report here the analysis of 12 PCL (10 primary and two secondary) by metaphase and FISH analysis combined with oligonucleotide array data (244 k, Agilent). Interphase‐FISH results were compared with those from a series of 861 newly diagnosed patients with MM. Cytogenetic analysis was successful on 11 patients, all of whom showed clonal chromosomal abnormalities. Compared with MM, t(11;14)(q13;q32) (42% versus 15%; P = 0.027) and t(14;16)(q32;q23) (25% versus 4%; P = 0.010) were more frequent in PCL, although neither the specific partner chromosome involved in the IgH translocation nor the ploidy status predicted for survival. Chromosomes 1, 8, 13, and 16 showed the highest number of copy number alterations with 8q24 being the chromosomal region most frequently involved. In eight of 12 patients we found abnormalities (translocations, one amplification, small deletions, and duplications) that directly targeted or were very close to MYC. Only four of these changes were detected by routine FISH analysis using commercial probes with the others exclusively detected by arrays. Quantitative reverse transcription polymerase chain reaction demonstrated that these different abnormalities were associated with increased levels of MYC mRNA. We conclude that MYC dysregulation by complex mechanisms is one of the major molecular events in the oncogenesis of PCL. Β© 2009 Wiley‐Liss, Inc.


πŸ“œ SIMILAR VOLUMES


Upregulation of stem cell genes in multi
✍ Gustav Lehne; Unn-Hilde Grasmo-Wendler; Jeanne-Marie Berner; Leonardo A. Meza-Ze πŸ“‚ Article πŸ“… 2009 πŸ› Elsevier Science 🌐 English βš– 828 KB

The transmembrane transporter P-glycoprotein (P-gp) encoded by ABCB1, is one major cause for multidrug resistance (MDR). We compared the genomic profile and gene expression pattern of the P-gp positive K562VCR cells with parental P-gp negative K562wt cells. In K562VCR array CGH revealed amplificatio

Immunophenotypic spectrum of plasma cell
✍ Michael D. Linden; Andrew J. Fishleder; Raymond R. Tubbs; Hoon Park πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 370 KB πŸ‘ 2 views

Four cases of plalsma cell leukemia (PCL) are reported that illustrate the variable immunotype of this disorder in contriast with the immunologic profile described for normal B-cell maturation and typical multiple myeloma (MM). Mature B-lymphocytes express B l antigen (Ag) and surface immunoglobulin

Plasma Cell Leukemia of the Breast
✍ Ravikanth Balaji; Krishnankutty Nair Ramachandran; Nileena Nayak; Santhosh Thyag πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 95 KB